C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
1.435
-0.165 (-10.31%)
At close: Apr 1, 2025, 4:00 PM
1.480
+0.045 (3.13%)
After-hours: Apr 1, 2025, 7:57 PM EDT

C4 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
1022542782891,5661,426
Upgrade
Market Cap Growth
-8.73%-8.73%-3.60%-81.55%9.83%-
Upgrade
Enterprise Value
-10037104111,1081,506
Upgrade
Last Close Price
1.443.605.655.9032.2033.13
Upgrade
PS Ratio
2.807.1413.429.2934.2042.95
Upgrade
PB Ratio
0.471.181.131.004.025.08
Upgrade
P/TBV Ratio
1.181.181.131.004.025.08
Upgrade
EV/Sales Ratio
1.031.035.020.3524.2045.36
Upgrade
Debt / Equity Ratio
0.300.300.290.300.110.08
Upgrade
Asset Turnover
0.100.100.050.070.100.13
Upgrade
Quick Ratio
5.495.496.216.236.158.58
Upgrade
Current Ratio
5.715.716.346.466.368.69
Upgrade
Return on Equity (ROE)
-45.58%-45.58%-49.50%-37.76%-25.03%-47.41%
Upgrade
Return on Assets (ROA)
-20.17%-20.17%-21.53%-17.27%-11.32%-14.58%
Upgrade
Return on Capital (ROIC)
-24.46%-24.46%-25.06%-20.02%-13.95%-23.88%
Upgrade
Earnings Yield
-103.38%-41.44%-47.58%-44.38%-5.36%-4.65%
Upgrade
FCF Yield
-64.14%-25.71%-38.98%-38.58%-5.64%-4.76%
Upgrade
Buyback Yield / Dilution
-39.75%-39.75%-1.59%-6.13%-304.93%-728.80%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q